[{"Assets_0_Q2_USD":1761511000.0,"CommonStockSharesConverted_0_Q2_shares":50225000.0,"CommonStockSharesOutstanding_0_Q2_shares":50225000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":-209222000.0,"NetIncomeLossConverted_1_Q2_USD":-145996000.0,"NetIncomeLossConverted_2_Q2_USD":-261120000.0,"StockholdersEquity_0_Q2_USD":1457534000.0,"EarningsPerShareBasic_1_Q2_USD":-2.91,"EarningsPerShareBasic_2_Q2_USD":-5.22,"RevenuesConverted_1_Q2_USD":7851000.0,"RevenuesConverted_2_Q2_USD":23808000.0,"Ticker":"BLUE","CIK":"1293971","name":"BLUEBIRD BIO, INC.","OfficialName":"bluebird bio Inc. Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"301448421.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20180802"}]